TRT suppresses your natural LH and FSH production within weeks. Without these signals, your Leydig cells stop producing intratesticular testosterone, and your testes gradually lose function and volume. HCG (human chorionic gonadotropin) is the tool that preserves this system: but it is not a set-and-forget addition. HCG changes your blood work in ways that require their own monitoring strategy.
Think of HCG as a stand-in for LH. It binds to the same receptor on Leydig cells, stimulating intratesticular testosterone production and maintaining testicular volume. The difference from your natural LH is potency: HCG has a longer half-life (about 36 hours versus 20 minutes for LH) and a stronger receptor affinity, which means its effects on steroidogenesis are more pronounced and longer-lasting.
When you run HCG alongside TRT, your bloodwork tells a specific story, and you need to read it correctly. The goal is to maintain intratesticular testosterone production sufficient for spermatogenesis, but your serum total testosterone will now reflect both exogenous and endogenous sources. A common mistake is chasing a supraphysiological total testosterone number while ignoring estradiol; HCG's LH mimicry directly upregulates aromatase in Leydig cells, so even a modest HCG dose can push estradiol notably higher even when total testosterone looks stable. If you see estradiol climbing above the reference range while total testosterone is stable, that is a finding to bring to whoever manages your HCG dosing rather than something to adjust yourself — the fix might be the HCG dose, the schedule, or something else entirely, and that is their call to make from the full picture. For fertility monitoring, your LH will read near zero on lab work, which is expected, so rely on FSH and a semen analysis at the 8 to 12 week mark to confirm intratesticular production is adequate. If sperm count remains low despite normal testicular volume, checking prolactin and discussing whether an FSH-stimulating medication is appropriate is a conversation for a fertility specialist, because HCG alone cannot drive the full spermatogenic cascade.
How HCG Changes Your Blood Work
Adding HCG to TRT is not neutral. It introduces a second source of testosterone production (exogenous + intratesticular), which affects several markers. The most clinically significant changes are:
- E2 rises more than expected. Leydig cells express aromatase. When you stimulate them with HCG, the intratesticular testosterone they produce is partially converted to estradiol right at the source. This is why many men on TRT + HCG need a lower testosterone dose to keep E2 in the same range.
- Total testosterone may increase. The intratesticular testosterone produced in response to HCG adds to your exogenous testosterone. If you are targeting a specific trough level, adding HCG can mean your testosterone dose needs revisiting — a decision for whoever manages your protocol, not a fixed percentage to apply yourself.
- Prolactin can rise. HCG has weak TSH-like activity and can stimulate prolactin release in some men. If you notice libido issues after adding HCG, check prolactin: it may be the cause, not E2.
- Free testosterone may drop. The estradiol rise from HCG can increase SHBG production, which reduces free testosterone even when total T is unchanged. Checking free T is essential when adding HCG.
The E2 Amplification Effect
Dosing: Maintenance vs. Fertility
The right HCG dose depends on your goal. Testicular maintenance requires less HCG than fertility restoration, and the monitoring markers differ between the two protocols.
HCG Doses by Goal
| Marker | Testicular Maintenance | Fertility Protocol |
|---|---|---|
| HCG dose | 250 IU 2x/week | 500 IU 3x/week (or daily 250 IU) |
| Testosterone | Keep TRT dose, monitor E2 | May reduce TRT dose or pause entirely |
| Key markers | E2, prolactin, free T | Semen analysis, FSH, LH, E2 |
| Goal | Preserve testicular volume and function | Restore spermatogenesis |
| Monitoring cadence | Blood work every 8-12 weeks | Semen analysis every 4-8 weeks |
For maintenance, 250 IU twice weekly is sufficient for most men to preserve testicular volume and intratesticular testosterone production. Increasing beyond this dose raises E2 without proportional benefit. For fertility protocols, the dose is higher because the goal is not just Leydig cell stimulation: it is maintaining high intratesticular testosterone levels that support the final stages of spermatogenesis.
For fertility protocols, HCG dosing typically runs considerably higher than a maintenance protocol, sustaining the supraphysiologic intratesticular testosterone needed for spermatogenesis. At this level, LH is effectively replaced by HCG, but FSH remains suppressed by exogenous testosterone, so men with severely low baseline sperm counts often need HMG or recombinant FSH added to complete the signal — a decision a fertility specialist makes based on the full picture, not something to add on your own. Bloodwork must be drawn at a consistent point relative to an HCG injection to get a reproducible E2 reading, and you should expect estradiol to run meaningfully above your TRT baseline. The most common mistake is checking a semen analysis after only four weeks; full spermatogenesis takes 70 to 90 days, so testing that early will understate progress. If sperm count stays low despite an adequate trial, that is grounds to go back to the specialist managing the protocol to reassess the approach, not to escalate the dose yourself.
The HCG + HMG Advantage
Monitoring HCG with Blood Work
When you add HCG to TRT, your blood work schedule needs to account for its longer half-life and its effect on steady-state hormone levels. Here are the practical guidelines:
- Draw at HCG trough: Just like with testosterone, draw immediately before your next HCG dose. This gives the most reproducible result. Drawing too close to an HCG injection will spike your values artificially.
- Check sensitive E2 (LC/MS-MS): The immunoassay for estradiol is unreliable in men, especially when E2 is elevated from HCG stimulation. The LC/MS-MS method is more accurate and avoids false high readings.
- Monitor prolactin: If you notice nipple sensitivity, libido changes, or delayed ejaculation after starting HCG, check prolactin. It is a less common side effect but under-recognized.
- Free testosterone matters more: HCG can raise SHBG through E2 stimulation, which reduces free T even when total T is stable. Always check free T (by equilibrium dialysis if possible) when monitoring HCG response.
For fertility monitoring specifically, blood work gives useful but incomplete information. LH and FSH levels tell you whether your pituitary is active, and intratesticular testosterone levels correlate with spermatogenesis, but the only definitive test is semen analysis. A normal sperm count confirms that your HCG protocol is working. Low count or motility means the protocol needs revisiting with whoever manages it — the options include increasing HCG dose, adding HMG, or both, but which one applies depends on the full picture.
Research backs the core premise here: a study of men on TRT (Hsieh et al., Journal of Urology) found that adding low-dose HCG preserved semen parameters over more than a year of follow-up, with no patient becoming azoospermic, while TRT alone is well known to suppress spermatogenesis in a large share of men. The takeaway: HCG works, but its effects on blood work require active management — particularly E2, which rises predictably and needs to be monitored with the sensitive assay.
The key to interpreting HCG therapy on bloodwork is understanding the feedback loop. Exogenous testosterone suppresses your pituitary's LH and FSH, but HCG acts as an LH analog, directly stimulating Leydig cells to produce intratesticular testosterone. This keeps the testes active, preserving spermatogenesis. However, this intratesticular production can spill into serum, pushing your total testosterone higher than expected. On a typical HCG maintenance protocol, do not be alarmed if your total testosterone reads well above your target range. The common mistake is chasing a specific number and reducing your testosterone dose on your own, which can crash your free T and leave you symptomatic — that trade-off is exactly why it is a protocol decision, not a self-adjustment. Instead, pay attention to the estradiol spike and bring it to whoever manages your protocol if it's elevated on a sensitive assay, since that is what actually drives symptoms and is the more useful thing to flag. Your next step is to run a full panel every eight weeks, checking total T, free T, sensitive E2, and FSH. If FSH is still suppressed, that is a sign the HCG dose isn't achieving the fertility goal, and is worth revisiting with whoever manages the protocol.